Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Kleinman
Ami Kleinman, Haifa IL
| Patent application number | Description | Published |
|---|---|---|
| 20110185223 | Target Operating System and File System Agnostic Bare-Metal Restore - A system, method, and computer program product for performing a bare-metal restore, the system including a target storage device, and a target computer configured to boot independent of the target storage device, expose the target storage device to a restoring computer after the target computer has booted, and act as a conduit for the restoring computer to perform a bare-metal restore of backup data onto the target storage device, and the method including booting a target computer independent of a target storage device, exposing the target storage device to a restoring computer after the target computer has booted, and causing the target computer to act as a conduit for the restoring computer to perform a bare-metal restore of backup data onto the target storage device. | 07-28-2011 |
Edward F. Kleinman, Pawcatuck, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20100184737 | IMIDAZOLE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS - The present invention relates to compounds of Formula I | 07-22-2010 |
Fredi Kleinman, Rishon Le Zion IL
| Patent application number | Description | Published |
|---|---|---|
| 20110021376 | Method for Analyzing a Glycomolecule - The invention relates generally the structural analysis of glycomolecule-containing macromolecules, such as those that occur either attached to proteins (proteoglycans, glycoproteins), lipids, or as free saccharides. | 01-27-2011 |
Heidi Kleinman, Princeton Junction, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090158500 | Cuff for storing object around wrist - A method of making a cuff by obtaining a piece of flexible material in the shape of a rectangle having first and second longitudinal edges, front and back faces, and first and second latitudinal edges; folding over the first and second latitudinal edges to meet the parallel fold lines; uniting the latitudinal edges to the fold lines to form first and second hems; folding a first half of the flexible material back over a second half of the flexible material along the third fold line so that the front face is on the interior and hems are on the exterior forming a tube; uniting the first and second longitudinal edges to form a flat tube having a closed tube edge, which is divided into a first closed tube edge and a second closed tube edge; folding the first closed tube edge over the second closed tube edge along a fourth fold line, which is perpendicular to the closed tube edge, so that the second hem is brought adjacent to but does not overlap the first hem to form a folded flattened tube; uniting the first closed tube edge over the second closed tube edge; turning the folded flattened tube inside out to form a cuff so that the front face forms an exterior surface of the cuff. | 06-25-2009 |
Hynda K. Kleinman, Kensington, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20090023663 | Thymosin beta 4 compositions and methods - A method of treatment for skin, dermal or epidermal tissue utilizes a composition including an actin-binding polypeptide which may include amino acid sequence LKKTET [SEQ ID NO: 1] or a conservative variant thereof. | 01-22-2009 |
| 20110124550 | THYMOSIN BETA 4 PROMOTES WOUND REPAIR - The present invention relates to methods of treatment for treating or preventing injury to cardiovascular or heart tissue in a subject in need thereof by administering an effective amount of thymosin β4 (Tβ4) peptide. | 05-26-2011 |
Joel E. Kleinman, Washington, DC US
| Patent application number | Description | Published |
|---|---|---|
| 20100105623 | SCHIZOPHRENIA-RELATED ISOFORM OF KCNH2 AND DEVELOPMENT OF ANTIPSYCHOTIC DRUGS - The invention is related to a novel primate specific brain isoform of the potassium channel KCNH2 and genetic association with risk for schizophrenia. | 04-29-2010 |
Lawrence Charles Kleinman, Allentown, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20080313544 | PROGRAMMED APPARATUS AND SYSTEM FOR DYNAMIC DISPLAY OF PRESENTATION FILES - A method of preparing and displaying a cumulative presentation and a presentation system are provided. A listing of available individual presentation files is provided through a user interface. Each of the presentation files comprises a plurality of presentation slides. A user is queried through the user interface to select presentation files from the available individual presentation files for inclusion in a cumulative presentation in a selected presentation order. A listing of presentation files selected by the user is displayed in the user interface. In response to a first command received from the user, a first slide from a first presentation from the cumulative presentation is provided to a display device for display thereon. In response to a second command received from the user, a second slide from the cumulative presentation is provided to the display device for display thereon. | 12-18-2008 |
Mark Ellsworth Kleinman, Lexington, KY US
| Patent application number | Description | Published |
|---|---|---|
| 20120064010 | CCR3 and its Ligands Are Therapeutic and Diagnostic Targets for Neovascular Age-Related Macular Degeneration - The results presented herein demonstrate the specific expression of CCR3 in CNV endothelial cells in humans with AMD, and despite the expression of its ligands, eotaxin-1, -2, and -3, neither eosinophils nor mast cells are present in human CNV. The genetic or pharmacological targeting of CCR3 or eotaxins as disclosed herein inhibited injury-induced CNV in mice. CNV suppression by CCR3 blockade was due to direct inhibition of endothelial cell proliferation, and was uncoupled from inflammation as it occurred in mice lacking eosinophils or mast cells and was independent of macrophage and neutrophil recruitment. CCR3 blockade was more effective at reducing CNV than vascular endothelial growth factor-A (VEGF-A) neutralization, which is currently in clinical use, and, unlike VEGF-A blockade, not toxic to the mouse retina. In vivo imaging with CCR3-targeting quantum dots located spontaneous CNV invisible to standard fluorescein angiography in mice before retinal invasion. CCR3 targeting is useful in reducing vision loss due to AMD through early detection and therapeutic angioinhibition. | 03-15-2012 |
William B. Kleinman, Indianapolis, IN US
| Patent application number | Description | Published |
|---|---|---|
| 20100121390 | PARTIAL OR COMPLETE PROSTHETIC REPLACEMENT ARTHROPLASTY OF THE DISTAL RADIOULNAR JOINT - System, including methods, apparatus, and kits, for replacement of at least one surface region of a distal radioulnar joint using at least one prosthesis. In some embodiments, the system may provide restoration of normal, unconstrained biomechanics of the joint, which may preserve rotation and translation and ensure durability of the joint. | 05-13-2010 |
Yossie Kleinman, Rehovot IL
| Patent application number | Description | Published |
|---|---|---|
| 20080249393 | METHOD AND APPARATUS FOR ENHANCEMENT AND QUALITY IMPROVEMENT OF ANALYTE MEASUREMENT SIGNALS - While measuring analytes in an object, movements between the object and a device that is taking the measurement may adversely effect the accuracy of the measurements. A probe that engages an object includes a sticky surface that comes into contact with the object to alleviate the relative movement between the probe and the object. The sticky substance can be applied in a variety of manners and embodiments and in general, helps to reduce the relative movement. In addition, the probe may include the ability to apply pressure to the object. The pressure can range from a slight pressure to help reduce relative movement to a pressure that exceeds systolic pressure, thereby constricting the flow of blood through the object. | 10-09-2008 |